Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Sai Murali Krishna Pulukuri, Hua Liao et al.|Nature Chemical Biology|2017Cited by 228
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Stephen Grossman et al.|Journal of Medicinal Chemistry|2021Cited by 205
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S. Lightcap, Dennis Huszar, Pengfei Yu et al.|Science Translational Medicine|2021Cited by 139
Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor ProliferationXingyue He, Neil Bence|PLoS ONE|2015Cited by 60